biotech

Bio-Analyst

Research Platform
person
Tier-BPublic-ready6/20/2026

Bacopa

Cognition, memory, and focus is the main area connected here, and any felt benefit should be read together with the human evidence base.

Some human supplement-context evidence is present and directly informs the score.

Representative tier calculated from paper evidence that passed the collection audit.

Papers analyzed
60
Caution signal
Low
Representative score
66.6
Cognition, memory, and focus

Main benefit evidence

The representative ingredient tier is calculated from these target-level evidence groups.

Cognition and focus
4 studiesTier-B
Cognition, memory, and focus
Fairly consistent positive signal in studiesFelt benefit focusSupplement context
Potential benefit studied in Cognition and focus.
Open metrics
>
Cognition, memory, and focus
No direct rate reported. Read direction and evidence strength together.
Evidence score
66.0
Score reflects signal strength. Tier also considers paper count, repetition, and study context.

Recent research

Updated This Month10 new papers

10 new papers were added in this period. No new risk signal was identified.

What's new

10 new papers were added.No new risk signal was identified.

Most notable recent finding

This is the most meaningful new study in the latest update.
review
Why it mattersIt ranked highest among the newly collected papers for this ingredient in the latest update.
View paper

Study dosage range (reference only)

Lower dose
300
mg/day
Higher dose
600
mg/day
Dosages used in research papers, shown as reference context.
Not personal dosing instructions, recommendations, or safety limits.

Key cautions to review

Standalone side-effect signals and combination cautions are listed separately.

Caution index
0.8
Caution band: Low
Caution signals
1
Side effects + combos + curated rules
Key precautions
No combination caution signal is clear enough to show right now. This does not guarantee safety.
Standalone side effects, combination cautions, and positive combos are separated below.

Standalone side effects

Adverse effect signal1 papers
The ethanolic extract of Bacopa Monniera was reported to show minor signs of catalepsy in rat animal models compared to the control group.human · unknown

Evidence summaries

Paper IDs and full lists are private. Only study types and summaries are shown.

Key Evidence #1
Public scholarly dataCitation signal: 112
review

These reports present data on the clinical, cellular activities, phytochemistry, and biological applications that may be used in new drug treatment for Alzheimer disease.

Key Evidence #2
Public scholarly dataCitation signal: 102
review

Bacopa monnieri has anti-apoptotic and antioxidant actions and can repair damaged neurons, stimulate kinase activity, restore synaptic function, improve nerve transmission, and increase neuroprotection.

Key Evidence #3
Public scholarly dataCitation signal: 94
observational

Results suggest that B. monnieri can improve attention, cognitive processing, working memory partly via the suppression of AChE activity, and cholinergic and monoaminergic functions in healthy elderly.

3 more summariesLimited representative sample by study type.
>
Public scholarly dataCitation signal: 83
review

Deep insights are provided into the therapeutic implications of Brahmi as a lead formulation for treating neurological disorders and exerting cognitive-enhancing effects in cognition and neuroprotection.

Public scholarly dataCitation signal: 82
observational

Cheminformatics and system pharmacological approaches revealed that Bacopa compounds have several curative activities in regulating the various biological processes of NDs and also pave the way for the treatment of various diseases in modern medicine.

Public scholarly dataCitation signal: 81
review

The animal studies and in vivo evidence for Bacopa monnieri as a potential therapeutic antioxidant to reduce oxidative stress and improve cognitive function are discussed and future studies incorporate neuroimaging particularly magnetic resonance spectroscopy

Bacopa
arrow_backBack to list